We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHAU icon
5851
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$95.2M
$0 ﹤0.01%
17
-1
-6% -$23
CHKP icon
5852
Check Point Software Technologies
CHKP
$13B
– –
-48
Closed -$6K
CIBR icon
5853
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.6B
– –
-231
Closed -$9K
CIFRW
5854
DELISTED
Cipher Mining Warrant
CIFRW
$0 ﹤0.01%
44
– –
CLB icon
5855
Core Laboratories
CLB
$569M
$0 ﹤0.01%
+15
New +$351
CLLS
5856
Cellectis
CLLS
$283M
– –
-26,362
Closed -$56K
CLSD
5857
DELISTED
Clearside Biomedical
CLSD
$0 ﹤0.01%
+4
New +$78
CLST icon
5858
Catalyst Bancorp
CLST
$69.2M
– –
-100
Closed -$1K
CMCM
5859
Cheetah Mobile
CMCM
$94.7M
$0 ﹤0.01%
32
– –
CNBS icon
5860
Amplify Seymour Cannabis ETF
CNBS
$74.8M
$0 ﹤0.01%
9
+3
+50% +$177
CNF
5861
CNFinance Holdings
CNF
$38.8M
– –
0
– –
CNRG icon
5862
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$207M
– –
-7,735
Closed -$634K
CNTB
5863
Connect Biopharma Holdings
CNTB
$139M
– –
-10,398
Closed -$9K
CNVS icon
5864
Cineverse
CNVS
$63.7M
$0 ﹤0.01%
5
-1,344
-100% -$13.6K
COE
5865
51Talk Online Education Group
COE
$113M
– –
-18
Closed –
CORN icon
5866
Teucrium Corn Fund
CORN
$164M
$0 ﹤0.01%
+1
New +$26
CORT icon
5867
Corcept Therapeutics
CORT
$12.2B
– –
-488
Closed -$10K
CPZ
5868
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$268M
– –
-88
Closed -$1K
CRDL
5869
Cardiol Therapeutics
CRDL
$173M
– –
-22,456
Closed -$11K
CREG
5870
DELISTED
Smart Powerr
CREG
$0 ﹤0.01%
+3
New +$551
CRESY
5871
Cresud
CRESY
$748M
– –
-11
Closed –
CRGO icon
5872
Freightos
CRGO
$65.1M
$0 ﹤0.01%
+31
New +$162
CSQ icon
5873
Calamos Strategic Total Return Fund
CSQ
$3.35B
$0 ﹤0.01%
+1
New +$14
CTRM icon
5874
Castor Maritime
CTRM
$19.8M
$0 ﹤0.01%
4
-493
-99% -$5.43K
CTXR icon
5875
Citius Pharmaceuticals
CTXR
$19.8M
– –
-22
Closed –
233 234
235
236 237

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.